Insider Shareholders with Indirect Ownership of Day One Biopharmaceuticals, Inc. (DAWN)
This section provides a comprehensive overview of the insiders with indirect ownership of Day One Biopharmaceuticals, Inc. (DAWN). You can find the latest updates on their holdings.
Day One Biopharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Atlas Venture Fund Xi, L.P.
> 10% Shareholder |
9,002,776 | 0 | 1 |
|
Samuel C. Blackman
HEAD OF R&D |
1,000,000 | 0 | 1 |
|
Jeremy Bender
CHIEF EXECUTIVE OFFICER |
1,052,451 | 571,875 | 4 |
|
Papanek Julie Grant
Director |
7,489,776 | 2,834,344 | 26 |
| 766,667 | 0 | 1 | |
|
Takeda Pharmaceutical Co Ltd
> 10% Shareholder |
57,224 | 407,482 | 5 |